Episode description
This is a free preview of a paid episode. To hear more, visit www.mindbodyhealthpolitics.orgShow Notes:
* Dr. George Greer talks about the most interesting and important thing happening in the psychedelic world right now: the Bipartisan Congressional Psychedelics Advancing Therapies (PATH) Caucus. This caucus aims to pass legislation for a carve-out from the NIH budget to support psychedelic research. (03:46)
* Dr. Greer shares his pioneering research on MDMA-assisted couples therapy, which yielded insights and strengthened relationships with minimal side-effects. (07:00)
* Dr. Greer emphasizes the importance of mindset, setting, and therapy in achieving positive outcomes from psychedelic experiences. (12:30)
* Dr. Greer explains the difference between psychedelic and psycholytic therapy. (12:30)
* Dr. Greer talks about the risks and benefits of using psychedelics as a catalyst for growth and healing. (12:30)
* Dr. Greer stresses the importance of responsible use of psychedelics, including screening, preparation, and integration, to minimize harm and maximize benefit. (12:30)
* Dr. Greer talks about the potential unwanted psychological complications of psychedelic therapy, including psychosis and trauma. (12:30)
* Dr. Greer discusses the challenges of funding psychedelic research and the need for responsible guidance to realize the promise of this field. (12:30)
Links and Resources
* Bipartisan Congressional Psychedelics Advancing Therapies Caucus
* MDMA Studies for PTSD Treatment (Multidisciplinary Association for Psychedelic Studies)
* NYU Psilocybin Cancer Anxiety Study